Patent ID: 11918577
Assignee: FUNDACIÓ HOSPITAL UNIVERSITARI VALL D'HEBRONINSTITUT DE RECERCA
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method for topical eye treatment and/or prevention of retinal neurodegeneration associated with glaucoma, comprising administering a pharmaceutical or veterinary topical eye composition comprising a dipeptidyl peptidase-4 inhibitor selected from the group consisting of sitagliptin, saxagliptin, vildagliptin, linagliptin, anagliptin, teneligliptin, alogliptin, trelagliptin, gemigliptin, omarigliptin, a pharmaceutically acceptable salt thereof, and mixtures thereof, together with a topical pharmaceutically or veterinary acceptable excipient and/or carrier, to a subject in need thereof, optionally wherein the subject is human.